MVRX

MVRx is a medical device company that introduces ARTO System, a transcatheter annular reduction therapy. The ARTO System is a unique endovascular therapy for mitral valve regurgitation associated with congestive heart failure. The system treats heart failure by reducing the backward leakage of blood through the mitral valve thereby increasing the forward flow of blood to the rest of the body. ARTO directly reshapes the mitral annulus and improves leaflet coaptation by shortening the minor axis of the mitral valve through inward displacement of the septal and lateral walls. This reestablishes normal anatomic relationships and decreases regurgitation.